David O'Toole
Director of Finance/CFO at AVITA MEDICAL, INC.
Net worth: 211 170 $ as of 2024-05-30
Profile
David D.
O'Toole is currently a Member of The American Institute of Certified Public Accountants, a Member of the California Society of Certified Public Accountants, a Member of the Southern California Biomedical Council, and the Chief Financial Officer of AVITA Medical, Inc. He started his role as Chief Financial Officer at AVITA Medical, Inc. in 2023.
He also currently holds a position at Deloitte Touche Tohmatsu Services LLC.
In the past, Mr. O'Toole served as an Independent Director at MediciNova, Inc. from 2012 to 2014.
He was also the Chief Financial Officer & Senior Vice President at Codexis, Inc. from 2012 to 2014.
From 2014 to 2017, he held the position of Chief Financial Officer & Senior Vice President at Soleno Therapeutics, Inc. Prior to that, he was the Chief Financial Officer of Response Genetics, Inc. from 2010 to 2012.
From 2008 to 2010, he served as the Chief Financial Officer & Executive Vice President at Abraxis BioScience, Inc. Before transitioning to these roles, he worked at Deloitte & Touche LLP from 1992 to 2008, where he held the position of Partner-Strategic Client Group.
He also worked at Arthur Anderson & Co. as a Tax Manager-International from 1984 to 1992.
Mr. O'Toole obtained his undergraduate degree from the University of Arizona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVITA MEDICAL INC
0.09% | 2024-05-30 | 21,974 ( 0.09% ) | 211 170 $ | 2024-05-30 |
David O'Toole active positions
| Companies | Position | Start |
|---|---|---|
| AVITA MEDICAL, INC. | Director of Finance/CFO | 2023-06-14 |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Corporate Officer/Principal | - |
| California Society of Certified Public Accountants | Corporate Officer/Principal | - |
Southern California Biomedical Council
 Southern California Biomedical Council Miscellaneous Commercial ServicesCommercial Services Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany. | Corporate Officer/Principal | - |
Former positions of David O'Toole
| Companies | Position | End |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | 2023-03-01 |
| SOLENO THERAPEUTICS, INC. | Director of Finance/CFO | 2017-09-10 |
| MEDICINOVA, INC. | Director/Board Member | 2014-06-15 |
| CODEXIS, INC. | Director of Finance/CFO | 2014-05-31 |
| RESPONSE GENETICS, INC | Director of Finance/CFO | 2012-08-19 |
Training of David O'Toole
| University of Arizona | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 5 |
|---|---|
| RESPONSE GENETICS, INC | Health Technology |
| MEDICINOVA, INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| AVITA MEDICAL, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Commercial Services |
| California Society of Certified Public Accountants | |
| California Healthcare Institute | Health Technology |
Southern California Biomedical Council
Southern California Biomedical Council Miscellaneous Commercial ServicesCommercial Services Southern California Biomedical Council, also known as SoCalBio, is an organization that aims to promote the growth and development of the life sciences industry. The non-profit company is based in Los Angeles, CA. The company provides leadership, advocacy, and support to their members, and foster collaboration within the industry. The CEO of the company is Ahmed Enany. | Commercial Services |
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
| Arthur Anderson & Co. |
- Stock Market
- Insiders
- David O'Toole
